Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6650
+0.0950 (6.05%)
NASDAQ· Last Trade: May 20th, 3:21 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors